MedTrace Logo

Articaine Efficacy and Safety for Children Below Age of 4-years

NCT04061265 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2020-02-17

No results posted yet for this study

Summary

Pain control is one of the significant behavior determinants in the dental office and shaping the future attitude toward dentistry, especially in children. One of widely used local anesthetic agents is articaine hydrochloride because of its superior potency, over traditionally used 2% lidocaine. Therefore, this study intends to get the benefits of articaine efficiency and apply it in children.

Conditions

  • Behaviour Assessment
  • Pain

Interventions

DRUG

Articaine 4%/Epi 1:100000 Inj Cart 1.7Ml

Local anesthetic agent

DRUG

lidocaine hydrochloride 2% and epinephrine 1:100000

Local anesthetic agent

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Ahmad Elheeny · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
37 Months
Max Age
47 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-25
Primary Completion
2020-01-15
Completion
2020-01-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04061265 on ClinicalTrials.gov